Avlon, United Kingdom

Avara acquired its Avlon facility close to the city of Bristol, United Kingdom from AstraZeneca. The site is a Center of Excellence and continues to manufacture intermediates and APIs for two AstraZeneca drugs. It has developed and manufactured APIs for nearly half a century, and over 200 employees operate its five large-scale cGMP API plants, two large-scale milling facilities, and a large-scale cGMP laboratory.